Unlearn.AI Announces Series A Extension with New Investment from Epic Ventures, Alumni Ventures Group, and Global Pharma Company Eisai
Round Type
Series A
San FranciscoOtherBiotechnologyMedia And EntertainmentData And AnalyticsHealth CareScience And EngineeringArtificial IntelligenceDescription
Unlearn®, developer of the first machine-learning platform that creates Digital Twins used to populate Intelligent Control Arms in clinical studies, today announced that Eisai, a leading global research and development-based pharmaceutical company, has joined the company’s world-class syndicate of investors as part of its Series A extension along with Epic Ventures and Alumni Ventures Group. In April 2020, Unlearn announced Series A financing led by 8VC with participation from DCVC, DCVC Bio and Mubadala Capital Ventures. The extension brings the Series A total to $15 million.
Quick answer
Unlearn raised an undisclosed amount in a Series A round, dated November 5, 2020. Unlearn is based in San Francisco, California, United States.
- How much did Unlearn raise?
- Unlearn raised an undisclosed amount in a Series A round on November 5, 2020.
- What does Unlearn do?
- Unlearn partners with pharma and biotech companies to design and optimize clinical trials using AI-powered digital twins.
- Where is Unlearn based and how big is it?
- Unlearn is based in San Francisco, California, United States. Fundz records about 70 employees.
- Who are the decision-makers at Unlearn?
- Fundz holds 2 contacts at Unlearn, including the Founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Media And Entertainment and Data And Analytics around the same time
Companies in the same sectors as Unlearn that raised within 45 days of this round, from Fundz verified event records.
- Viracta Therapeutics raised $40M on December 10, 2020.
- AliveCor, Inc. raised $56M on November 18, 2020.
- Geneos Therapeutics raised $10M on November 17, 2020.
- Edwards Lifesciences raised $114K (Pre-Seed) on November 13, 2020.
- Eko raised $65M (Series C) on November 9, 2020.
- Memo Therapeutics AG raised an undisclosed amount (Series B) on November 6, 2020.
Who to call at Unlearn, and when
A new round usually means Unlearn is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Unlearn raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Unlearn, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Unlearn. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Unlearn raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansUnlearn raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.